Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
8.57
+0.06 (0.76%)
Mar 4, 2026, 4:00 PM EST - Market closed
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $745.31 million as of March 4, 2026. Its market cap has increased by 15.75% in one year.
Market Cap
745.31M
Enterprise Value
215.11M
1-Year Change
15.75%
Ranking
Category
Stock Price
$8.57
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $745.31M, an increase of 555.50%. That is a compound annual growth rate of 19.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 755.30M | -16.46% |
| Dec 31, 2025 | 904.10M | 33.49% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
| Nov 5, 2015 | 113.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 777.20M |
| Gyre Therapeutics | 760.75M |
| Prime Medicine | 759.67M |
| AgomAb Therapeutics NV | 751.03M |
| Evommune | 746.18M |
| ProKidney | 722.00M |
| MiMedx Group | 711.63M |
| Theravance Biopharma | 698.27M |